Aspire Private Capital LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Aspire Private Capital LLC lifted its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 355.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,228 shares of the medical research company's stock after purchasing an additional 4,860 shares during the quarter. Aspire Private Capital LLC's holdings in IQVIA were worth $1,098,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. American National Bank & Trust purchased a new stake in shares of IQVIA during the first quarter worth approximately $26,000. ST Germain D J Co. Inc. raised its position in IQVIA by 66.1% in the first quarter. ST Germain D J Co. Inc. now owns 191 shares of the medical research company's stock worth $34,000 after acquiring an additional 76 shares in the last quarter. GKV Capital Management Co. Inc. purchased a new position in IQVIA in the fourth quarter worth $39,000. Lee Danner & Bass Inc. purchased a new position in IQVIA in the fourth quarter worth $44,000. Finally, Zions Bancorporation N.A. raised its position in IQVIA by 55.2% in the fourth quarter. Zions Bancorporation N.A. now owns 239 shares of the medical research company's stock worth $47,000 after acquiring an additional 85 shares in the last quarter. Hedge funds and other institutional investors own 89.62% of the company's stock.

IQVIA Trading Up 0.2%

IQVIA stock opened at $154.96 on Friday. The stock has a market cap of $26.81 billion, a PE ratio of 21.11, a P/E/G ratio of 1.69 and a beta of 1.28. The stock has a 50-day moving average price of $148.21 and a 200 day moving average price of $176.10. IQVIA Holdings Inc. has a 52 week low of $134.65 and a 52 week high of $252.88. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 2.19.

IQVIA (NYSE:IQV - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The medical research company reported $2.70 EPS for the quarter, topping analysts' consensus estimates of $2.63 by $0.07. The firm had revenue of $3.83 billion during the quarter, compared to analysts' expectations of $3.77 billion. IQVIA had a return on equity of 29.16% and a net margin of 8.61%. The firm's quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.54 EPS. Equities research analysts predict that IQVIA Holdings Inc. will post 10.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have issued reports on IQV. Citigroup reiterated a "neutral" rating on shares of IQVIA in a research report on Thursday, May 22nd. Wall Street Zen cut IQVIA from a "buy" rating to a "hold" rating in a research report on Wednesday, March 12th. Barclays cut their price objective on IQVIA from $170.00 to $165.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 7th. Truist Financial cut their price objective on IQVIA from $263.00 to $216.00 and set a "buy" rating for the company in a research report on Thursday, April 10th. Finally, Redburn Partners set a $188.00 target price on IQVIA in a report on Friday, May 23rd. Eight research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $226.32.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.